Development and internal validation of a radiomics-clinical combined model for predicting axillary pathological complete response in clinically node-positive breast cancer patients after neoadjuvant chemotherapy - Quiz - MDSpire

Development and internal validation of a radiomics-clinical combined model for predicting axillary pathological complete response in clinically node-positive breast cancer patients after neoadjuvant chemotherapy

  • By

  • Weitao Yan

  • Wenxuan Lu

  • Ying Dai

  • Xiangchao Meng

  • Kai Feng

  • July 10, 2026

  • 0 min

Share

Original Source(s)

Development and internal validation of a radiomics-clinical combined model for predicting axillary pathological complete response in clinically node-positive breast cancer patients after neoadjuvant chemotherapy

  • by Weitao Yan, Wenxuan Lu, Ying Dai, Xiangchao Meng, Kai Feng

  • July 10, 2026

Related Content

Case Report: Aplastic anemia associated with parvovirus B19 infection following neoadjuvant pembrolizumab-based chemoimmunotherapy for triple-negative breast cancer

Subtype-specific sonographic signatures and clinicopathological features of metaplastic breast cancer: a 50-case cohort study

A sentiment analysis and topic modeling of weibo discourse on public perceptions of breast cancer